First Time Loading...

Australian Clinical Labs Ltd
ASX:ACL

Watchlist Manager
Australian Clinical Labs Ltd Logo
Australian Clinical Labs Ltd
ASX:ACL
Watchlist
Price: 2.44 AUD 1.24% Market Closed
Updated: May 4, 2024

Profitability Summary

Australian Clinical Labs Ltd's profitability score is 65/100. We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

65/100
Profitability
Score

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Past Growth

To be successful and remain in business, both growth and profitability are important and necessary. Net Income growth is often seen as a sign of a company's efficiency from an operational standpoint, but is influenced heavily by a company's goals and challenges and should therefore be assessed in conjunction with other metrics like revenue and operating income growth.

Margins

Profit margins represent what percentage of sales has turned into profits. Simply put, the percentage figure indicates how many cents of profit the company has generated for each dollar of sale.

Profit margins help investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Earnings Waterfall
Australian Clinical Labs Ltd

Revenue
697.1m AUD
Cost of Revenue
-126.1m AUD
Gross Profit
571m AUD
Operating Expenses
-506.3m AUD
Operating Income
64.7m AUD
Other Expenses
-28.8m AUD
Net Income
35.9m AUD

Margins Comparison
Australian Clinical Labs Ltd Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
AU
Australian Clinical Labs Ltd
ASX:ACL
489.2m AUD
82%
9%
5%
US
Cigna Group
XMUN:CGN
94.9B EUR
13%
5%
3%
US
Cigna Corp
NYSE:CI
99.9B USD
13%
5%
3%
US
CVS Health Corp
NYSE:CVS
70B USD
15%
4%
2%
US
Laboratory Corporation of America Holdings
NYSE:LH
17B USD
28%
9%
4%
DE
Fresenius SE & Co KGaA
XETRA:FRE
15.7B EUR
23%
5%
-3%
US
Quest Diagnostics Inc
NYSE:DGX
15.2B USD
33%
14%
9%
DE
Fresenius Medical Care AG
XMUN:FME
11.9B EUR
25%
7%
3%
DE
Fresenius Medical Care AG & Co KGaA
XETRA:FME
11.5B EUR
25%
7%
3%
US
DaVita Inc
NYSE:DVA
11.9B USD
31%
13%
6%
US
Oak Street Health Inc
NYSE:OSH
9.5B USD
4%
-22%
-24%
Country AU
Market Cap 489.2m AUD
Gross Margin
82%
Operating Margin
9%
Net Margin
5%
Country US
Market Cap 94.9B EUR
Gross Margin
13%
Operating Margin
5%
Net Margin
3%
Country US
Market Cap 99.9B USD
Gross Margin
13%
Operating Margin
5%
Net Margin
3%
Country US
Market Cap 70B USD
Gross Margin
15%
Operating Margin
4%
Net Margin
2%
Country US
Market Cap 17B USD
Gross Margin
28%
Operating Margin
9%
Net Margin
4%
Country DE
Market Cap 15.7B EUR
Gross Margin
23%
Operating Margin
5%
Net Margin
-3%
Country US
Market Cap 15.2B USD
Gross Margin
33%
Operating Margin
14%
Net Margin
9%
Country DE
Market Cap 11.9B EUR
Gross Margin
25%
Operating Margin
7%
Net Margin
3%
Country DE
Market Cap 11.5B EUR
Gross Margin
25%
Operating Margin
7%
Net Margin
3%
Country US
Market Cap 11.9B USD
Gross Margin
31%
Operating Margin
13%
Net Margin
6%
Country US
Market Cap 9.5B USD
Gross Margin
4%
Operating Margin
-22%
Net Margin
-24%

Return on Capital

Return on capital ratios give a sense of how well a company is using its capital (equity, assets, capital employed, etc.) to generate profits (operating income, net income, etc.). In simple words, these ratios show how much income is generated for each dollar of capital invested.

Return on Capital Comparison
Australian Clinical Labs Ltd Competitors

Country Company Market Cap ROE ROA ROCE ROIC
AU
Australian Clinical Labs Ltd
ASX:ACL
489.2m AUD
18%
6%
16%
9%
US
Cigna Group
XMUN:CGN
94.9B EUR
11%
3%
9%
7%
US
Cigna Corp
NYSE:CI
99.9B USD
11%
3%
9%
7%
US
CVS Health Corp
NYSE:CVS
70B USD
10%
3%
8%
6%
US
Laboratory Corporation of America Holdings
NYSE:LH
17B USD
5%
2%
7%
4%
DE
Fresenius SE & Co KGaA
XETRA:FRE
15.7B EUR
-3%
-1%
2%
1%
US
Quest Diagnostics Inc
NYSE:DGX
15.2B USD
13%
6%
11%
8%
DE
Fresenius Medical Care AG
XMUN:FME
11.9B EUR
4%
1%
4%
3%
DE
Fresenius Medical Care AG & Co KGaA
XETRA:FME
11.5B EUR
4%
1%
4%
3%
US
DaVita Inc
NYSE:DVA
11.9B USD
78%
4%
11%
8%
US
Oak Street Health Inc
NYSE:OSH
9.5B USD
464%
-26%
-41%
-35%
Country AU
Market Cap 489.2m AUD
ROE
18%
ROA
6%
ROCE
16%
ROIC
9%
Country US
Market Cap 94.9B EUR
ROE
11%
ROA
3%
ROCE
9%
ROIC
7%
Country US
Market Cap 99.9B USD
ROE
11%
ROA
3%
ROCE
9%
ROIC
7%
Country US
Market Cap 70B USD
ROE
10%
ROA
3%
ROCE
8%
ROIC
6%
Country US
Market Cap 17B USD
ROE
5%
ROA
2%
ROCE
7%
ROIC
4%
Country DE
Market Cap 15.7B EUR
ROE
-3%
ROA
-1%
ROCE
2%
ROIC
1%
Country US
Market Cap 15.2B USD
ROE
13%
ROA
6%
ROCE
11%
ROIC
8%
Country DE
Market Cap 11.9B EUR
ROE
4%
ROA
1%
ROCE
4%
ROIC
3%
Country DE
Market Cap 11.5B EUR
ROE
4%
ROA
1%
ROCE
4%
ROIC
3%
Country US
Market Cap 11.9B USD
ROE
78%
ROA
4%
ROCE
11%
ROIC
8%
Country US
Market Cap 9.5B USD
ROE
464%
ROA
-26%
ROCE
-41%
ROIC
-35%

Free Cash Flow

Free cash flow (FCF) is the money a company has left over after paying its operating expenses and capital expenditures. The more free cash flow a company has, the more it can allocate to dividends, paying down debt, and growth opportunities.

If a company has a decreasing free cash flow, that is not necessarily bad if the company is investing in its growth.

See Also

Discover More